Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes.

Rickels MR, Kong SM, Fuller C, Dalton-Bakes C, Ferguson JF, Reilly MP, Teff KL, Naji A.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1780-5. doi: 10.1210/jc.2013-1764. Epub 2013 Oct 1.

2.

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV.

N Engl J Med. 2000 Jul 27;343(4):230-8.

3.

Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.

Rickels MR, Kong SM, Fuller C, Dalton-Bakes C, Ferguson JF, Reilly MP, Teff KL, Naji A.

Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1217-24. doi: 10.1152/ajpendo.00667.2013. Epub 2014 Apr 1.

4.

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.

Rickels MR, Liu C, Shlansky-Goldberg RD, Soleimanpour SA, Vivek K, Kamoun M, Min Z, Markmann E, Palangian M, Dalton-Bakes C, Fuller C, Chiou AJ, Barker CF, Luning Prak ET, Naji A.

Diabetes. 2013 Aug;62(8):2890-7. doi: 10.2337/db12-1802. Epub 2013 Apr 29.

5.

Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.

Roelen DL, Huurman VA, Hilbrands R, Gillard P, Duinkerken G, van der Meer-Prins PW, Versteeg-van der Voort Maarschalk MF, Mathieu C, Keymeulen B, Pipeleers DG, Roep BO, Claas FH.

Clin Exp Immunol. 2009 Apr;156(1):141-8. doi: 10.1111/j.1365-2249.2008.03812.x. Epub 2009 Jan 21.

6.

Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.

Warnock GL, Meloche RM, Thompson D, Shapiro RJ, Fung M, Ao Z, Ho S, He Z, Dai LJ, Young L, Blackburn L, Kozak S, Kim PT, Al-Adra D, Johnson JD, Liao YH, Elliott T, Verchere CB.

Arch Surg. 2005 Aug;140(8):735-44.

PMID:
16103282
7.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
8.

Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes.

Rickels MR, Naji A, Teff KL.

J Clin Endocrinol Metab. 2006 Jun;91(6):2138-44. Epub 2006 Mar 28.

PMID:
16569741
9.

Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.

Froud T, Baidal DA, Faradji R, Cure P, Mineo D, Selvaggi G, Kenyon NS, Ricordi C, Alejandro R.

Transplantation. 2008 Dec 27;86(12):1695-701. doi: 10.1097/TP.0b013e31819025e5.

10.

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.

Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro R.

Am J Transplant. 2005 Aug;5(8):2037-46.

11.

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.

Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DE.

JAMA. 2005 Feb 16;293(7):830-5. Erratum in: JAMA. 2005 Apr 6;293(13):1594.

PMID:
15713772
12.

Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.

O'Connell PJ, Holmes-Walker DJ, Goodman D, Hawthorne WJ, Loudovaris T, Gunton JE, Thomas HE, Grey ST, Drogemuller CJ, Ward GM, Torpy DJ, Coates PT, Kay TW; Australian Islet Transplant Consortium.

Am J Transplant. 2013 Jul;13(7):1850-8. doi: 10.1111/ajt.12250. Epub 2013 May 13.

13.

Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.

Christiansen E, Vestergaard H, Tibell A, Hother-Nielsen O, Holst JJ, Pedersen O, Madsbad S.

Diabetes. 1996 Sep;45(9):1267-75.

PMID:
8772733
14.

Primary graft function, metabolic control, and graft survival after islet transplantation.

Vantyghem MC, Kerr-Conte J, Arnalsteen L, Sergent G, Defrance F, Gmyr V, Declerck N, Raverdy V, Vandewalle B, Pigny P, Noel C, Pattou F.

Diabetes Care. 2009 Aug;32(8):1473-8. doi: 10.2337/dc08-1685.

15.

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

Hirshberg B, Rother KI, Digon BJ 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM.

Diabetes Care. 2003 Dec;26(12):3288-95.

PMID:
14633816
16.

Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.

Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L, Di Carlo V, Federlin K, Pozza G, Bretzel RG.

J Clin Invest. 1996 Jun 1;97(11):2611-8.

17.

Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.

O'Connell PJ, Hawthorne WJ, Holmes-Walker DJ, Nankivell BJ, Gunton JE, Patel AT, Walters SN, Pleass HC, Allen RD, Chapman JR.

Med J Aust. 2006 Mar 6;184(5):221-5.

PMID:
16515432
18.

Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes.

Ang M, Meyer C, Brendel MD, Bretzel RG, Linn T.

Diabetologia. 2014 Mar;57(3):623-32. doi: 10.1007/s00125-013-3120-9. Epub 2013 Dec 5.

PMID:
24305963
19.

Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.

Toso C, Morel P, Bucher P, Mathe Z, Demuylder-Mischler S, Bosco D, Berney T, Oberholzer J, Shapiro J, Oberholzer J, Philippe J.

Transplantation. 2003 Oct 15;76(7):1133-4. No abstract available.

PMID:
14557767
20.

Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF.

Froud T, Baidal DA, Ponte G, Ferreira JV, Ricordi C, Alejandro R.

Cell Transplant. 2006;15(7):613-20.

PMID:
17176613

Supplemental Content

Support Center